Page last updated: 2024-08-21

nuciferine and Obesity

nuciferine has been researched along with Obesity in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's7 (100.00)2.80

Authors

AuthorsStudies
Ao, H; Chen, L; Peng, C; Tang, F; Wan, Y; Wu, JJ; Xia, J; Xu, JF; Yang, Y1
Duan, L; Gong, F; Guo, X; Lyu, X; Pan, H; Wang, L; Xu, H; Yang, H; Zhu, H1
Hao, R; Si, F; Zhang, C; Zheng, J; Zhu, X1
Chang, XY; Chen, X; Hu, MG; Lu, J; Lyu, X; Mi, X; Sun, L; Wu, C; Yu, Y1
Gong, S; Li, B; Liu, M; Qian, S; Wang, J; Wang, Y; Wei, B; Wei, M; Yao, W1
Cui, HT; Liao, JB; Wang, HW; Wen, WB; Xiong, WT; Yang, ZX; Zhang, ZY1
Du, XL; Fang, ZY; Gao, XX; Li, XW; Liu, GW; Ouyang, HL; Shi, Z; Song, YX; Wang, Z; Yu, H; Zhu, YW1

Reviews

1 review(s) available for nuciferine and Obesity

ArticleYear
Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases.
    Pharmacological research, 2022, Volume: 175

    Topics: Animals; Anti-Obesity Agents; Aporphines; Humans; Lotus; Obesity; Plant Leaves

2022

Other Studies

6 other study(ies) available for nuciferine and Obesity

ArticleYear
Distinct AMPK-Mediated FAS/HSL Pathway Is Implicated in the Alleviating Effect of Nuciferine on Obesity and Hepatic Steatosis in HFD-Fed Mice.
    Nutrients, 2022, Apr-30, Volume: 14, Issue:9

    Topics: AMP-Activated Protein Kinases; Animals; Aporphines; Diet, High-Fat; Fatty Liver; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Obesity

2022
Nuciferine Protects against Obesity-Induced Nephrotoxicity through Its Hypolipidemic, Anti-Inflammatory, and Antioxidant Effects.
    Journal of agricultural and food chemistry, 2023, Dec-06, Volume: 71, Issue:48

    Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Diet, High-Fat; Inflammation; Mice; NF-kappa B; Obesity; Oxidative Stress; Palmitic Acid

2023
Akkermansia muciniphila: A potential novel mechanism of nuciferine to improve hyperlipidemia.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 133

    Topics: Akkermansia; Animals; Anti-Bacterial Agents; Aporphines; Bacteroides; Biomarkers; Diet, High-Fat; Disease Models, Animal; Gastrointestinal Microbiome; Hyperlipidemias; Hypolipidemic Agents; Intestines; Lipids; Male; Metagenome; Metagenomics; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; RNA-Seq

2021
Nuciferine modulates the gut microbiota and prevents obesity in high-fat diet-fed rats.
    Experimental & molecular medicine, 2020, Volume: 52, Issue:12

    Topics: Animals; Aporphines; Diet, High-Fat; Dose-Response Relationship, Drug; Dysbiosis; Fatty Acids; Gastrointestinal Microbiome; Lipid Metabolism; Metabolome; Metabolomics; Metagenome; Metagenomics; Obesity; Protective Agents; Rats

2020
[Effect of nuciferine on gut microbiota and inflammatory response in obese model mice].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2021, Volume: 46, Issue:8

    Topics: Animals; Aporphines; Diet, High-Fat; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity

2021
Nuciferine improves high-fat diet-induced obesity
    Food & function, 2021, Jul-05, Volume: 12, Issue:13

    Topics: Animals; Aporphines; Autophagy; Caco-2 Cells; Diet, High-Fat; Dietary Supplements; Epithelium; Gastrointestinal Microbiome; HT29 Cells; Humans; Intestines; Male; Mice; Mice, Inbred C57BL; Obesity; Permeability; Weight Gain

2021